DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (71)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 71   Next >>

Possible Ribavirin side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 65.4 kg (143.8 pounds)

Reactions: Renal Failure

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Incivek
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Pegasys
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Other drugs received by patient: Zantac; Lisinopril; Ramipril



Possible Ribavirin side effects in male

Reported by a physician from Australia on 2012-08-14

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Deafness Neurosensory

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-24

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-28

Other drugs received by patient: Fungilin; Pristiq



Possible Ribavirin side effects in 64 year old female

Reported by a pharmacist from United States on 2012-08-09

Patient: 64 year old female, weighing 84.1 kg (185.0 pounds)

Reactions: Dialysis, Hyperuricaemia, Renal Failure Acute

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin



Possible Ribavirin side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible Ribavirin side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-08-02

Patient:

Reactions: Prostatitis, Autonomic Nervous System Imbalance, Anaemia, Hypotension, Malnutrition, General Physical Health Deterioration, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-09-27
    End date: 2012-07-26

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2012-07-26

Peginterferon Alfa-2B
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2012-07-26

Other drugs received by patient: Isentress; Truvada



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-07-26

Patient:

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22



Possible Ribavirin side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20

Patient: 62 year old female

Reactions: Confusional State, Activities of Daily Living Impaired, Disorientation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg, capsule, three times a day, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-19

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Adverse Event

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-03
    End date: 2012-05-13

Pegasys
    Indication: Disease Recurrence
    Start date: 2011-09-03
    End date: 2012-05-13

Incivek
    Dosage: 2 tablets 7-9 hrs apart

Victrelis
    Dosage: 12 a day

Ribavirin
    Dosage: (6) a day



Possible Ribavirin side effects in 53 year old male

Reported by a pharmacist from Canada on 2012-06-26

Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)

Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 60 year old male

Reported by a pharmacist from United States on 2012-06-26

Patient: 60 year old male

Reactions: Angioedema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: 500 mg;bid;
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg;q8h; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-04

Pegasys
    Dosage: 180 mcg;qw;
    Indication: Hepatitis C

Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril



Possible Ribavirin side effects in 61 year old male

Reported by a physician from United States on 2012-06-13

Patient: 61 year old male

Reactions: Gastrointestinal Motility Disorder, Pain, Impaired Work Ability, Emotional Disorder, Haemoglobin Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: bid
    Indication: Hepatitis C
    Start date: 2012-05-01

PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Other drugs received by patient: Vitamins E; Vitamins C



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: male

Reactions: Weight Decreased, Pruritus, Substance Use, Hunger, Abnormal Dreams, Back Pain, Polydipsia, Pain in Extremity, Eye Inflammation, Foreign Body Sensation in Eyes, Application Site Pain, Insomnia, Rash Erythematous, Pancreatitis, Injection Site Discolouration, Chills, Pain, Poor Quality Sleep, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Blood Glucose Increased, Decreased Appetite, Vomiting, Nausea, Musculoskeletal Chest Pain, Application Site Rash, Dysgeusia, Burning Sensation, Pollakiuria, Asthenia, Feeling Abnormal, Influenza

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2012-04-06

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-04-06



Possible Ribavirin side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 50 year old male

Reactions: Haemoglobin Decreased, Dyspnoea, Arthralgia, Abdominal Distension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: ; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

PEG-Intron
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Megace; Zoloft



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient: male

Reactions: Tinnitus, Faecal Incontinence, Loss of Consciousness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2011-07-22

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-22

Victrelis
    Indication: Hepatitis C
    Start date: 2011-08-20



Possible Ribavirin side effects in male

Reported by a physician from Spain on 2012-06-08

Patient: male

Reactions: Erectile Dysfunction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-02-25
    End date: 2011-09-07

Ribavirin
    Dosage: dosage: 1200 units not reported
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-02-25
    End date: 2011-09-07



Possible Ribavirin side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 55 year old female

Reactions: Intention Tremor, Motor Dysfunction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    End date: 2011-12-01

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in male

Reported by a physician from Australia on 2012-05-31

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Deafness Bilateral

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-24

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-28

Other drugs received by patient: Fungilin; Pristiq



Possible Ribavirin side effects in male

Reported by a physician from United States on 2012-05-29

Patient: male

Reactions: Retinal Exudates, Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 4 df;tid;po
    Administration route: Oral
    Indication: Hepatitis C



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: male

Reactions: Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-13
    End date: 2012-04-01



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-05-29

Patient: female

Reactions: Retinal Exudates, Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2B
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 4 df, tid; po
    Administration route: Oral
    Indication: Hepatitis C



Possible Ribavirin side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23

Patient: 60 year old male

Reactions: Listless, Nausea, Anaemia, Rash, Abdominal Discomfort, Subretinal Haematoma, Syncope, Fatigue, Gastrointestinal Disorder, Insomnia, Vision Blurred, Dizziness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg; tid; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-28
    End date: 2012-04-30

Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Other drugs received by patient: Nadolol



Possible Ribavirin side effects in female

Reported by a physician from Pakistan on 2012-05-15

Patient: female, weighing 59.0 kg (129.8 pounds)

Reactions: Dyspnoea, Gingival Bleeding, Hepatic Failure, Hyponatraemia, Altered State of Consciousness, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2010-01-18
    End date: 2010-04-22

Ribavirin
    Dosage: dose: 800
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-18
    End date: 2010-04-22

Other drugs received by patient: Lexotanil



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14

Patient: male

Reactions: Injection Site Discolouration, Weight Decreased, Pain, Chills, Substance Abuse, Hunger, Abdominal Pain Upper, Abnormal Dreams, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Decreased Appetite, Polydipsia, Back Pain, Vomiting, Pain in Extremity, Nausea, Eye Inflammation, Musculoskeletal Chest Pain, Dysgeusia, Burning Sensation, Rash Erythematous, Pollakiuria, Pancreatitis, Asthenia, Feeling Abnormal, Mobility Decreased, Influenza

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-04-06

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-04-06

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-04-06



Possible Ribavirin side effects in 48 year old female

Reported by a physician from France on 2012-05-11

Patient: 48 year old female

Reactions: Pancreatitis Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alisporivir
    Dosage: blinded
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-03
    End date: 2009-11-05

Neupogen
    Dosage: unk
    Indication: Neutropenia
    Start date: 2009-08-27

Ribavirin
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-03

Peginterferon Alfa-2A
    Dosage: 180 mug, qwk
    Indication: Hepatitis C
    Start date: 2009-02-03

Ramipril
    Dosage: 10 mg, qd
    Indication: Hypertension
    Start date: 2009-08-27

Amlodipine Besylate
    Dosage: 5 mg, qd
    Indication: Hypertension
    Start date: 2009-08-11

Other drugs received by patient: Neorecormon; Humalog; Zolpidem Tartrate



Possible Ribavirin side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: 65 year old male

Reactions: Blood Count Abnormal, Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-13
    End date: 2012-04-01

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from Venezuela on 2012-04-25

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Myalgia, Arthralgia, Anaemia, Mouth Ulceration, Neutropenia, Pyrexia, Asthenia, Epistaxis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-02-01

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01



Possible Ribavirin side effects in 54 year old male

Reported by a physician from Germany on 2012-04-18

Patient: 54 year old male, weighing 95.0 kg (209.0 pounds)

Reactions: Pneumonia Aspiration, Blood Creatine Phosphokinase Increased, Respiratory Failure, Incorrect Dose Administered, Suicide Attempt, Toxicity To Various Agents, Depression

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: 200 mg
    Indication: Hepatitis C

Boceprevir (Sch-503034)
    Dosage: 200 mg
    Indication: Hepatitis C

Interferon
    Indication: Hepatitis C



Possible Ribavirin side effects in male

Reported by a physician from United States on 2012-04-11

Patient: male

Reactions: Haemorrhage, Hepatitis C, Increased Appetite, Hypotension, Rash, Somnolence, Fatigue, Joint Swelling, Oedema Peripheral, Aspartate Aminotransferase Increased, Vertigo, Dizziness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Telaprevir
    Indication: Hepatitis C
    Start date: 2011-09-01

Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-01

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-09-01



Possible Ribavirin side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2011-07-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014